Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Bergh

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Lakartidningen|May 19, 2010
[Targeted drugs a chance for a better cure]Jonas Bergh, Bertil Jonsson
Lakartidningen|December 15, 2010
[Great risk of future problems for Swedish cancer care]Jonas Bergh, Nils Wilking
Lakartidningen|February 22, 2017
[Chemotherapy and targeted drugs to reinforce each other]Theodoros Foukakis, Jonas Bergh
Acta Obstetricia Et Gynecologica Scandinavica|November 20, 2023
Breast cancer during pregnancy-The oncologist's point of viewAlexios Matikas, Jonas Bergh
Current Breast Cancer Reports|August 28, 2012
Analysis of Cyclin D1 in Breast Cancer: A Call to ArmsNicholas P Tobin, Jonas Bergh
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerTheodoros Foukakis, Claudette Falato, Jonas Bergh
Breast (Edinburgh, Scotland)|September 12, 2009
Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancerAnnelie Liljegren, Jonas Bergh, Roser Castany
Breast Cancer Research : BCR|December 25, 2009
Breast tumour stroma is a prognostic indicator and target for therapyAnthony Howell, Goran Landberg, Jonas Bergh
Methods in Molecular Medicine|February 24, 2006
Sequencing of the tumor suppressor gene TP 53Barbro Linderholm, Torbjörn Norberg, Jonas Bergh
Nature Medicine|March 7, 2009
Stromal signature identifies basal breast cancersKristian Wennmalm, Arne Ostman, Jonas Bergh
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Lakartidningen|May 19, 2010
[Targeted drugs a chance for a better cure]Jonas Bergh, Bertil Jonsson
Lakartidningen|December 15, 2010
[Great risk of future problems for Swedish cancer care]Jonas Bergh, Nils Wilking
Lakartidningen|February 22, 2017
[Chemotherapy and targeted drugs to reinforce each other]Theodoros Foukakis, Jonas Bergh
Acta Obstetricia Et Gynecologica Scandinavica|November 20, 2023
Breast cancer during pregnancy-The oncologist's point of viewAlexios Matikas, Jonas Bergh
Current Breast Cancer Reports|August 28, 2012
Analysis of Cyclin D1 in Breast Cancer: A Call to ArmsNicholas P Tobin, Jonas Bergh
The New England Journal of Medicine|April 7, 2016
A 21-Gene Expression Assay in Breast CancerTheodoros Foukakis, Claudette Falato, Jonas Bergh
Breast (Edinburgh, Scotland)|September 12, 2009
Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancerAnnelie Liljegren, Jonas Bergh, Roser Castany
Breast Cancer Research : BCR|December 25, 2009
Breast tumour stroma is a prognostic indicator and target for therapyAnthony Howell, Goran Landberg, Jonas Bergh
Methods in Molecular Medicine|February 24, 2006
Sequencing of the tumor suppressor gene TP 53Barbro Linderholm, Torbjörn Norberg, Jonas Bergh
Nature Medicine|March 7, 2009
Stromal signature identifies basal breast cancersKristian Wennmalm, Arne Ostman, Jonas Bergh
Pageof 30